fda glp 1 compounding ban issued 25 warning letters to telehealth companies for false and misleading GLP-1 Medications – FDA Guidance

But tirzepatides success may come with a downside

Advanced Family Medical Care in Plano, TX, is now offering Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1 RAs) a class of medications with significant benefits

Consistent, extended sessions guarantee optimal outcomes

Mol Cell (2019) 74:3244

Katagiri D, Hamasaki Y, Doi K, Okamoto K, Negishi K, Nangaku M, Noiri E (2013) Protection of glucagon-like peptide-1 in cisplatin-induced renal injury elucidates gut-kidney connection

doi: 10.3389/fmicb.2022.979719 Received 27 June 2022 Accepted 14 September 2022 Published 06 October 2022 Volume 13 - 2022 Edited by Wanbo Tai, Shenzhen Bay Laboratory, China Reviewed by Lihui Guo, University of Amsterdam, Netherlands